EXOs derived from two EWS cell lines deprived of CD99 regulated gene expression in recipient cells and were able to inhibit cancer cell growth and migration while inducing cell differentiation in a panel of human patient-derived cell lines. This evidence concerns the gene CD99 and cancer.